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Abstract
Background: The use of acoustic forces to manipulate particles or cells at the microfluidic scale (i.e. acoustophoresis),
enables non-contact, label-free separation based on intrinsic cell properties such as size, density and compressibility.
Acoustophoresis holds great promise as a cell separation technique in several research and clinical areas. However, it has
been suggested that the force acting upon cells undergoing acoustophoresis may impact cell viability, proliferation or cell
function via subtle phenotypic changes. If this were the case, it would suggest that the acoustophoresis method would be a
less useful tool for many cell analysis applications as well as for cell therapy.
Methods:We investigate, for the first time, several key aspects of cellular changes following acoustophoretic processing. We
used two settings of ultrasonic actuation, one that is used for cell sorting (10 Vpp operating voltage) and one that is close to
the maximum of what the system can generate (20 Vpp). We used microglial cells and assessed cell viability and
proliferation, as well as the inflammatory response that is indicative of more subtle changes in cellular phenotype.
Furthermore, we adapted a similar methodology to monitor the response of human prostate cancer cells to
acoustophoretic processing. Lastly, we analyzed the respiratory properties of human leukocytes and thrombocytes to
explore if acoustophoretic processing has adverse effects.
Results: BV2 microglia were unaltered after acoustophoretic processing as measured by apoptosis and cell turnover assays
as well as inflammatory cytokine response up to 48 h following acoustophoresis. Similarly, we found that acoustophoretic
processing neither affected the cell viability of prostate cancer cells nor altered their prostate-specific antigen secretion
following androgen receptor activation. Finally, human thrombocytes and leukocytes displayed unaltered mitochondrial
respiratory function and integrity after acoustophoretic processing.
Conclusion: We conclude that microchannel acoustophoresis can be used for effective continuous flow-based cell
separation without affecting cell viability, proliferation, mitochondrial respiration or inflammatory status.
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Introduction
The use of acoustic forces to handle particles and cells in
microfluidic systems (i.e. microchannel acoustophoresis) is gaining
increased attention [1]. The application in which the acousto-
phoresis method can be used include particle manipulation [2,3],
depletion [4], washing [5,6,7], fractionation [8], rare event sorting
[9,10], concentration [11] and cell cycle synchronization [12].
This novel cell manipulation technique is label-free and enables
separation by unique cell properties, e.g. compressibility. In view of
its high reproducibility, reliability and the fact that this technology
can be applied to most cell types, acoustophoresis holds great
promise as a cell manipulation technique in several research and
clinical settings [13].
While acoustophoresis is emerging as a new technology in
several research areas, there are doubts to whether the induced
acoustic forces and fluid handling are harmful to the cells.
Questions that are relevant to this technology if acoustophoretic
applications are to be used with clinical setting. Earlier studies on
the impact of acoustic resonant systems on cells have been recently
reviewed by Wiklund (2012) [14]. Moreover, Ryll and coauthors
studied Chinese hamster ovary cells in a perfused macroscale
acoustic cell retention device for 50 days and concluded that no
harm was observed to this cell type [15]. In another study, Wang
and collaborators studied mouse hybridoma cells, which were
acoustically trapped in a high porosity polyester mesh with a low
intensity, resonant acoustic field [16], concluded that the acoustic
field produced a negligible effect on cell viability in a short-term
exposure. Similarly, Hultstro¨m and colleagues [17] as well as
Evander et al. [18], using cos-7 cells from fetal monkey kidney and
rat neural stem cells respectively, studied cell viability in an
acoustic trap. However, both studies concluded that cell viability
was not affected. Moreover, Evander et al. successfully grew yeast
cells within the trap to demonstrate that cell proliferation was not
affected [18].
Although acoustophoretic technology shows great promise,
acoustophoretic manipulation of cells in a clinical setting must be
studied in detail. Bazou and colleagues studied human liver
carcinoma cells (HepG2) in an acoustic trap and determined that
cell viability and proliferation were not affected [19]. Using a
continuous flow system, Jo¨nsson and coauthors separated eryth-
rocytes from lipid particles and concluded that there had been no
increase of hemolysis of erythrocytes after passing through an
acoustophoretic device [20]. Recently Dykes et al. removed
platelets from peripheral blood progenitor cell products by
acoustophoresis and cell viability and colony-forming abilities of
the progenitor cells was studied. Furthermore, morphological
studies as well as platelet activation assays concluded that the cells
were not harmed by the acoustophoretic treatment [21]. However,
the literature still lacks a thorough examination on the effect of
microchannel acoustophoresis using short-term acoustic exposure
times with long-term viability and phenotypic characterization.
Especially characterizations of important long-term functional
biological parameters such as inflammatory response, cell activa-
tion response and respiration have not been studied in detail.
If the acoustophoresis technology is used in the clinical setting,
the impact on cell survival and the subtle phenotypic changes that
may be induced must be investigated in detail. Hence, in this study
we examine several key cellular changes following acoustophoresis
and use microglial cells, a cell type known to readily react to
environmental cues to test cell viability and proliferation. We also
monitor more subtle changes in cellular phenotype by analyzing
inflammatory status after acoustophoretic processing. Finally, we
use similar methodology to examine the effect on human prostate
cancer cells and study the different properties of cell respiration
using human leukocytes and thrombocytes. Our studies indicate
that microchannel acoustophoresis can be tuned for effective cell
handling without having any effect of cell viability, proliferation,
respiration or inflammatory status.
Materials and Methods
Ethics Statement
The study was approved by the regional ethical review board of
Lund, Sweden (permit number 113/2008). Blood samples were
collected from healthy blood donors at the blood donor central,
Ska˚ne University Hospital, Lund. Samples were obtained after
written informed consent was acquired.
Acoustophoresis Device and Setup
The acoustophoresis chip design is illustrated in figure 1. The
acoustophoresis chip was fabricated in ,100.-silicon through
double sided photolithography and anisotropic wet etching using
KOH. A borofloat glass lid to seal the flow channel was anodically
bonded to the chip. The chip structure is comprised of trifurcation
inlet followed by a 20 mm long acoustic focusing channel (square
cross-section; 375 mm6150 mm) corresponding to a retention time
of about 1 second in the acoustic field for a flow rate of 100 mL
min21 and a trifurcation outlet region. For the viability
experiments only one inlet and outlet was used. The center outlet
flow rate was controlled by a syringe pump (WPI sp210iwz, World
Precision Instruments Inc., Sarasota, FL, USA) and set to 100 mL
min21 and the cell suspension was drawn into the center inlet from
an Eppendorf tube at the same speed. To avoid sedimentation in
the tube during the course of the experiments the cells were mixed
gently by pipetting. Samples were collected either by a 6-port 2-
way sample loop (V-451, Upchurch Scientific, Oak Harbor, WA,
USA) with a volume of 100 mL connected in series with the outlet
or directly in the syringe (for the human blood cell respiration
studies). To actuate the chip a piezoceramic transducer (PZ26,
resonant at 2 MHz, Ferroperm, Kvistgaard, Denmark) was used.
The piezoceramic was driven by a wave form generator (Agilent,
33250A) set at a frequency of 1.94 MHz, amplified by an in-
house-built amplifier. The voltage over the transducer was
measured using an oscilloscope (TDS 1002, Tektronix UK Ltd.,
Bracknell, UK). The temperature of the chip was controlled using
a Peltier element regulated by a Peltier regulator (TC2812-RS232,
CoolTronic GmbH, Beinwill am See, Switzerland) and set to 37uC
to limit effects emanating from elevated temperature exposure
caused by power dissipation in the piezo ceramic at elevated
operating voltage that could affect the viability of the cells. The
cells were processed through the chip and exposed to ultrasound at
either 10 or 20 Vpp operating voltage or run through the chip
without ultrasound exposure to reveal any influence of the
microfluidic system. Unprocessed cells were used as a control.
The acoustic energies the cells were exposed to were higher than
would normally be needed to focus cells in this chip for the
particular settings stated above. In this set up, thrombocytes were
less prone to focus in the middle of the microchannel due to their
small sizes.
Estimation of the Acoustic Energy Density
To estimate the acoustic energy density (Eac) inside the
acoustophoretic microchannel polystyrene microparticles
(,0.02%wt, Ø 7 mm) (Sigma-Aldrich. Co., St. Louis, MO, USA)
suspended in Triton X-100 (0.01%) in PBS were processed in the
device. To estimate Eac the microparticles were drawn into the
chip from the side inlets at flow rate of 50 mL min21 and a clean
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buffer was pumped into the center inlet at a flow rate of 450 mL
min21. The beads were then focused in the center of the channel
and collected from the center outlet at a flow rate of 250 mL min21
using two 6-port 2-way sample loops (V-451, Upchurch Scientific,
Oak Harbor, WA, USA), each with a volume of 100 mL. Excess
fluid was discarded from the side outlets also at a flow rate of
250 mL min21.
Material. The fluorescent marker for DNA 7-Aminoactino-
mycin D (7-AAD), the synthetic androgen agonist methyltrieno-
lone (R1881), 2,3-Bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetra-
zolium-5-carboxanilide(XTT), Giemsa stain, 29-(4-
hydroxyphenyl)-5-(4-methyl-1-piperazinyl)-2,59-bi-1H-benzimid-
azole trihydrochloride hydrate, bisBenzimide (Hoechst), and
Lipopolysacharide (LPS from Escherichia coli, serotype 026:B6)
were purchased from Sigma Aldrich (Stockholm, Sweden).
Tetramethylrhodamine, ethyl ester, perchlorate (TMRE) was
purchased from Invitrogen (Stockholm, Sweden). Cytokines were
detected using a Multiplex kit from Meso Scale Discovery
(Gaithersburg, USA).
Cell culture. The murine microglial BV2 cells were a kind
gift of Dr. Sandra Ceccatelli and were established and first
characterized 1992 by Bocchini et al. [22]. All Cell lines were
culture in DMEM (GIBCO) and supplemented with 10% fetal
bovine serum (FBS) (Sigma-Aldrich), 55 IU ml21 penicillin and
55 mg ml21 streptomycin (Sigma-Aldrich). For the experiments
performed with the BV2 cells and LPS, the media was
supplemented with 5% FBS. All cells were cultured at 37uC in a
humidified atmosphere containing 5% CO2. The human prostate
cancer cell lines DU145, LNCaP, PC3 and VCaP were all
obtained from the American Type Culture Collection (ATCC)
and grown according to ATCC recommendations.
Cell viability in BV2 cells. The BV2 microglial cells were
suspended (4 million cells mL21) in culture medium supplemented
with 2% serum to facilitate phenotypic/inflammatory changes of
the cells. After the acoustophoretic processing possible induction of
acute cell death was examined by dye exclusion using trypan blue.
XTT assay. 5000 BV2 cells per well were seeded in 96-well
plates after microchannel acoustophoretic processing and cultured
for 24 or 48 h. The XTT assay was performed following the
manufacture’s recommendation and the data are presented as
percentage in respect to the cells exposed to microfluidic handling
without ultrasound.
TMRE staining. 20,000 BV2 cells were seeded in 12-well
plates to measure their Mitochondrial potential (DY) after
acoustophoretic processing. A final concentration of 25 nM of
TMRE staining was added to the medium and the fluorescence
was measured using flow cytometry (FACS CantoII, FACSDiva
software, BD Biosciences, San Jose, USA).
Cell migration. BV2 cells were seeded in 6-well plates after
acoustophoretic processing. Twenty-four hours after seeding, a
yellow 100-ml-pipette tip was used to draw a line through the
confluent culture dish. After additional 24 h of culture, the width
of the line, i.e. how much cells had migrated, was analyzed.
Hoechst staining. BV2 cells were seeded in 12-well plates
and fixed in 4% PFA during 20 minutes at 37uC. The plates were
then washed twice with PBS and Hoechst was added at a
concentration of 1 mg mL21 in PBS for 10 min at room
temperature. After two more washes with PBS, mounting media
was added to the wells and the number of cells that presented
condensed nuclei was quantified using an inverted microscope.
For each well at least 300 cells were counted.
Clonogenic assay. 1000 BV2 cells were seeded in duplicates
in petri dishes and 10 mL of medium was added to each dish.
After three days, 5 mL of medium was exchanged with fresh
media. After seven days the media was carefully removed and the
cells were fixed with 70% ethanol during 10 min at room
temperature. After the fixation the cells were stained with 10% (v/
v) GIEMSA staining for 15 min at room temperature. The plates
were then washed with MilliQ water and dried after which they
were scanned and analyzed using ImageJ 1.43r software.
Immunoblot. After acoustophoretic processing, BV2 cells
were seeded in 6-well plates and after one day exposed to LPS for
24 h. The cells were then washed twice in PBS and lysed on ice
using loading buffer. Then, the cells were sonicated 3 times during
5 seconds each time while kept on ice. All samples were boiled for
4 min, resolved on 10% SDS polyacrylamide gels at 100 V and
transblotted onto nitro-cellulose membranes for 2 h at 30 V. The
membranes were blocked for at least 1 h in a buffer (5% non-fat
milk powder and 0.1% NaN3 in PBS, pH 7.4) and probed with
primary antibodies (diluted in 5% bovine serum albumin and
0.1% NaN3 in PBS, pH 7.4) against iNOS (Santa Cruz, sc-650;
1:1000) and b-actin (Sigma, A5316 1:4000) overnight. The
membranes were then washed in PBS containing 0.1% Tween-
20 and incubated with the secondary antibody (diluted 1:5000 in
2.5% milk in PBS) for 1 h and washed 3 times in PBS. The protein
bands were visualized by ECL (Amersham Biosciences) according
to the manufacturer’s instructions.
Cytokine analysis. After acoustophoretic processing, BV2
cells were seeded in 96-well plates. After 24 h, cells were exposed
Figure 1. Picture and illustration of the set up. (a) Photo of the
acoustophoresis microfluidic system first presented by Augustsson
et al. [27]. (b) Cross sectional view of cell distribution in the
microchannel without ultrasound (left) and with ultrasound forming
an ultrasound standing wave (right). (c) Illustration of acouscoustophor-
esis chip. For the present study, only one of the channel segments was
used allowing cells to be exposed to ultrasound.
doi:10.1371/journal.pone.0064233.g001
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to LPS for 24 h and the supernatants were collected. The cytokine
production was measure using the Meso Scale Discovery
electrochemiluminescence kit (Th1/Th2 cytokines, Ultra-Sensitive
kit, K15013C-1) using the manufacturer’s instructions.
Cell viability in prostate cancer cell lines. DU145, PC3,
LNCaP and VCaP cells were detached by trypsin/EDTA and
washed twice in PBS and re-suspended in complete cell growth
medium. Immediately after acoustophoretic processing (0 h)
trypan blue exclusion was used to estimate the percentage of
viable cells. The cells were counted in a Bu¨rker chamber and
afterward seeded in 6-well plates, (200,000 cells/well) and grown
for 24 or 48 h. Cells were harvested with trypsin/EDTA, washed
with PBS and subsequently stained with 7-AAD for 20 minutes.
Cell viability was estimated for 10,000 cells by flow cytometry
(FACS CantoII, FACSDiva software, BD Biosciences), 7-AAD-
negative cells with high forward scatters were selected as viable.
PSA secretion. Cell lines (LNCaP and VCaP) expressing the
androgen receptor (AR) were harvested and subjected to the
acoustophoretic processing. Unprocessed cells were used as a
control group. Cells were seeded in 96-well plates (10,000 cells/
well), and grown in complete growth medium for 24 h in the
presence of either R1881 (1 nM), or vehicle (PBS/DMSO). 80 mL
growth medium was removed from each well for PSA analysis.
The samples were stored at 220uC until analysis. PSA concen-
trations were measured using the DELFIA Prostatus Free/Total
PSA assay from PerkinElmer, Turku, Finland [23].
Human blood cell respiration. Thrombocytes and leuko-
cytes from three healthy blood donors were subjected to
acoustophoretic processing and mitochondrial function was
analyzed by high-resolution respirometry as described in Sjo¨vall
et al. [24].
Statistics. We used analysis of variance (ANOVA) for
statistical comparisons between experimental groups. Experiments
were performed in triplicates or more. Data are expressed as mean
6 SD and P,0.05 was considered as significantly different.
Results
Acoustic Energy Estimations
To estimate the acoustic energy (Eac) at the different driving
voltages, we used 7 mm diameter microparticles. Microparticles
were used instead of cells do to their homogenous size distribution,
which allows for a better measurement. The driving voltage
squared (Upp)
2 has a linear relation to the Eac in the following
expression;
U2pp
Etr
U2tr
~Eac~
p2ako
4
where Utr is the transition voltage applied when the transition from
particles exiting through the side outlets to exiting from the center
outlet takes place, Etr is the corresponding acoustic transition
energy, pa is the acoustic pressure amplitude and ko is the
compressibility of the suspending liquid. For this particular chip,
using the 7 mm polystyrene microparticles and a total flow rate of
500 mL min21, Utr
2 was measured to be 147 Vpp
2 and Etr was then
estimated from simulated particles trajectories to be 69 J/m3.
Through this expression Eac for the voltages of 10 Vpp and 20 Vpp
was calculated to be 47 J/m3 and 188 J/m3, which correspond to
acoustic pressure amplitudes of 0.639 MPa and 1.28 MPa,
respectively. These energy levels are comparable to other
acoustophoresis microchip processing devices, which commonly
operate at acoustic energy density levels of 10–100 J/m3 [25,26].
See Augustsson et al. 2012 for a more detailed description of the
acoustic energy density estimation [27].
Acoustic Cell Processing
Microchannel acoustophoretically processed cells may be
damaged due to hydrodynamic shear, ultrasonic exposure or high
temperatures. To avoid cell damage due to high temperatures, we
evaluated the effect of acoustophoresis on cell viability in a
controlled temperature environment (37uC). Hydrodynamic shear
damage was also excluded by using cells processed through the
chip without ultrasound exposure as controls.
In the acoustophoresis microchannel, cells were focused in the
center when operated at a half wavelength resonance at 2 MHz.
At amplitude of 10 Vpp, all cells were focused in the center of the
microchannel. Amplitude of 20 Vpp was also employed to generate
a stronger acoustic field than needed to focus cells, and thereby
enable the study of possible harmful effects on the cells when
exposed to elevated acoustic radiation forces. The setup allowed
maximum 25 Vpp, however using this high voltage generated
temperature fluctuations above the temperature criteria of 37˚C.
We tested the effect 25 Vpp on immediate cell death (trypan blue
exclusion) using the BV2 microglial cells without detecting any
adverse effect (data not shown). As a control, cells were processed
through the chip without an active ultrasound (function generator
set to 0 Vpp). In order to study the effect of acoustophoresis on cell
survival and elucidate possible adverse effects when using
acoustophoresis for cell sorting, a standard acoustophoresis chip
was used (fig. 1, described in Material and Methods). Cells were
passed through the chip at a flow rate of 100 mL min21
corresponding to a retention time of about 1 second in the
acoustic field, a retention time relevant for most acoustophoretic
processing.
Acoustic Cell Processing in a Microchannel does not Alter
Cell Death and Viability of Microglial Cells
Viability and cell death analysis. We set out to investigate
possible deleterious effects of acoustophoresis by using the
microglia cell line BV2, an immortalized mouse microglial cell
used widely and successfully in medical research [28]. Using
trypan blue exclusion, no adverse effects on the acute cell death
induced by the acoustophoresis handling could be detected (Ctrl,
cells not entering the acoustophoresis chip 9.765.7% cell death; 0
Vpp, 11.468.8% cell death; 10 Vpp, 8.967.0% cell death; 20 Vpp,
11.666.9% cell death).
Next, we studied possible long-term cellular alterations beyond
the acute effect of acoustophoresis. After going through the
acoustophoresis chip, BV2 cells were seeded again for 24 h or 48 h
to investigate possible long-term effects. First, we used XTT assay
(mitochondrial dehydrogenase activity) to study a possible
alteration in the viability/proliferation of acoustophoresis. How-
ever, no differences in viability of the cells exposed to the different
conditions could be detected in the XTT assay at either 10 or 20
Vpp of acoustic focusing at any time point, 24 or 48 h, after
seeding (fig. 2a). To further elucidate the effect of acoustophoresis,
BV2 cells were PFA-fixed then Hoechst stained at 24 and 48 h
and the number of cells undergoing cell death, containing
apoptotic bodies, were quantified. Despite a progressive cell death
from 24 to 48 h, we did not find any changes in number of cells
undergoing apoptosis due to the acoustophoretic processing
(fig. 2b). Furthermore, we did not detect any changes in the
mitochondrial potential (indirectly measurement of cells at risk of
undergoing apoptosis) by TMRE due to acoustophoresis (fig. 2c).
Similarly, the cell migration speed as described previously [29],
was unaltered after acoustophoretic processing at 24 to 48 h after
Impact of Acoustophoresis on Cells
PLOS ONE | www.plosone.org 4 May 2013 | Volume 8 | Issue 5 | e64233
culturing (data not shown). The cellular changes over a longer
time period (7 days) was also assessed to study a possible alteration
in cell turnover using a clonogenic assay however, no adverse
effect were detected (fig. 2d) similar to our earlier time points (24
or 48 h).
Inflammatory response. Although we could not detect any
acoustophoresis-induced alterations on cell death or cell viability,
minor cellular alterations and phenotypic changes cannot be ruled
out. In this aspect, inflammatory microglial cells are suitable cells
to detect subtle differences in their inflammatory response due to
the exposure of acoustic forces. We therefore explored the
possibility that acoustophoretic processing could alter the inflam-
matory response triggered by a proinflammatory response.
Lipopolyssacharide (LPS) is a lipoglycan found in the outer
membrane of Gram-negative bacteria and a very potent Toll-like
receptor 4 (TLR4) ligand and inducer of inflammation. LPS-
Figure 2. Unaltered viability of BV2 microglial cell line following acoustophoretic processing (10Vpp and 20Vpp). BV2 cells were passed
through the acoustophoresis chip with the function generator set at 0, 10 and 20 Vpp. After going through the chip, the BV2 cells were seeded again
for 24 and 48 h. Cell viability was measured by XTT (a), apoptotic nuclei appearance (b) and decrease of mitochondrial potential -Ym- (c), showing no
difference between experimental groups. Similar, no difference was detected by clonogenic assay (d) used to study survival and proliferation at 7
days following acoustophoretic processing. The graphs show the results from at least three separate experiments and the data are shown as means
6 SD. Significance value P,0.05, ns denotes non-significant.
doi:10.1371/journal.pone.0064233.g002
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challenged BV2 cells were analyzed for the production of
inducible nitric oxide synthase, iNOS, (fig. 3a,b) that is highly
induced under inflammatory stimulus (such as LPS). The medium
was also collected and used to measure the microglial release of
proinflammatory cytokines (IL-1b, IL-12 and TNF-a; fig. 3c,d,e)
and anti-inflammatory molecules (IL-10; fig. 3f). We found that,
both the protein expression of proinflammatory iNOS and the
release of pro- and anti-inflammatory cytokines upon LPS-
challenge were unaltered after exposure to acoustophoretic
processing (fig. 3).
Influence of Acoustophoresis on Viability or Secretory
Function of Prostate Cancer Cells
Acoustophoresis-based microfluidic devices are currently being
explored as a mean to enrich and discriminate viable from non-
viable tumor cells in peripheral blood [27]. Therefore, we initiated
a detailed characterization of the viability and secretory function
of tumor cells subsequent to subjecting them to acoustophoretic
processing. We first characterized the prostate cancer cell lines
DU145, PC3, LNCaP in reference to cell viability/proliferation
using the same XTT assay that was used for the viability test of the
BV2 microglial cells. We did not find any changes in cell viability
at either 24 or 48 h after acoustophoretic processing (data not
shown). Subsequently, we determined the extent of cell death
using trypan blue exclusion directly following acoustophoretic
processing without observing any change in cell death for the
different prostate cancer cell lines, DU145, PC3, LNCaP or
VCaP. Finally, we examined cell death at 24 and 48 h using
florescence activated cell sorting (FACS) and gated cells for 7-
AAD-uptake. Again, similar to our results above, no adverse effect
following acoustophoretic processing when compared to unpro-
cessed cells was identified (fig. 4a–d).
We went on to determine whether acoustophoresis alters the
functional properties of viable cells processed through the
microchip. PSA secretion is a sensitive indicator for androgen
receptor (AR) signaling activity in AR-dependent tumor cells. We
used the prostate cancer cell lines LNCaP and VCaP and studied
both endogenous PSA secretion as wells as secretion following
administration of the synthetic androgen R1881. We did not find
any significant differences in PSA secretion in tumor cells
subjected to acoustophoretic processing compared to unprocessed
cells, neither after administration of R1881 nor for unstimulated
cells. There were no measurable differences in reference to cells
processed through the microchip in absence of ultrasound or when
they were exposed to ultrasound at increasing voltage (fig. 5a–b).
Mitochondrial Respiratory Function of Human Blood
Cells is not Altered Following Acoustophoresis
Acoustophoretic processing of human blood is an emerging
research field of acoustic cell manipulation in microchannels. To
further elucidate possible cellular alteration due to acoustophor-
esis, we exposed thrombocytes and leukocytes isolated from
human blood to the same acoustic treatment used for the BV2
microglial cells and prostate cancer cells described above. High-
resolution respirometry was performed to evaluate mitochondrial
respiratory function and integrity. Furthermore, endogenous
oxygen consumption was evaluated in intact cells (data not
shown), and respiration during maximal oxidative phosphorylation
(Oxphos) and maximal flux through the electron transport system
was assessed using a multiple substrate/inhibitor titration protocol
in digitonin-permeabilized cells.
We studied the maximal respiration during Oxphos using both
complex I- and complex II-linked substrates for thrombocytes
(fig. 6a) and leukocytes (fig. 6b) and found no effect following
acoustophoretic processing. We further investigated the remaining
respiratory activity following inhibition of ATP synthase with
oligomycin, so called LEAK or state 4 respiration, and found no
differences in respiratory activity following passage through the
acoustophoresis microchip. We also checked for differences in
other respiratory states, without detecting any alterations due to
acoustophoretic processing (data not shown). Any process inter-
fering with metabolic pathways leading to respiratory inhibition
would be readily detected at maximal Oxphos respiration.
Similarly, any process interfering with inner membrane integrity
or increased utilization of proton motive force for other purposes
than ADP phosphorylation would be readily detected at LEAK/
state 4 respiration. Thus, there is no indication of any negative
mitochondrial effect or an increase in energy demand in the cells
by acoustophoretic cell sorting.
Discussion
The acoustophoretic technology allows non-contact cell han-
dling based on intrinsic cell properties that includes size, density
and compressibility which enables the development of novel label-
free cell sorting strategies [27]. However, extensive analysis on the
effects of sorting methodology are necessary not only for a
technique to be established in clinical settings but also to assure
that research results do not get tainted due to a harsh sorting
technology. For a cell handling or sorting technologies to be valid
for clinical or research purposes, they need be non-perturbing for
the cells processed. Hence, in this study we have performed a
comprehensive study with different cells using various techniques
aimed at determining any cellular alterations that acoustophoretic
processing could induce. Our conclusions in this study are relevant
for acoustophoretic sorting of cells in microfluidic systems at flow
rate in the range up to 100 ml/min (channel cross-sections
375*150 mm) and with retention times in the acoustic standing
wave for about 1 second, at pressures up to 1.28 MPa, at an
actuation frequency of 2 MHz.
The effect of acoustophoretic processing on microglial cells was
first elucidated. These cells are the inflammatory surveillance cells
of the brain similar to macrophages in other tissues [30]. Microglia
respond easily to subtle changes in the microenvironment,
including exposure to radiation [31], nanoparticles [32] and
minor temperature changes [33]. The murine microglial cell line
BV2 is an inflammatory cell line widely used in medical research
[28]. We first used this cell line and found no changes in survival/
apoptosis proliferation or migration at 24 h, 48 h or 7 days after
acoustophoretic processing using both manual cytological analysis
and flow cytometry (TMRE). After demonstrating that acousto-
phoresis did not alter aspects of viability, we further determined if
acoustophoresis could induce any changes in the inflammatory
state of the cells. Microglia exposed to acoustophoretic processing
were also stimulated with LPS activating the pattern recognition
receptor TLR4. This receptor is known to activate the MyD88 or
TRAM/TRIF pathways. Stimulation of these pathways will
trigger intracellular pathways activating inflammatory transcrip-
tion factors (IRF/NFkB/CREB/AP-1) that will lead to iNOS
activation and cytokine release. Our data show no alteration in
iNOS and cytokine response following acoustophoretic processing
suggesting that these inflammatory pathways are not affected by
acoustophoresis. In view of the susceptible activation of microglial
cells by various stimulus, our data suggest that acoustophoresis is a
mild cell-handling technology.
Prostate cancer is the most commonly diagnosed cancer in men
and has the second highest death incidence [34]. However, the
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Figure 3. Inflammatory response of BV2 cells upon LPS challenge following acoustophoresis is not changed. After acoustophoretic
processing, BV2 cells were seeded and stimulated the next day with LPS for 24 h. We observed no alteration due to acoustophoretic processing in the
expression of iNOS (inducible nitric oxide synthase)(a,b), the release of proinflammatory cytokines IL-1b (x), IL-12 (d), TNF-a (e) or the anti-
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molecular background of prostate tumor progression is currently
not completely understood. Most prostate cancer cells require
androgen stimulation for growth and proliferation and androgen
deprivation therapy is the first line of treatment for most prostate
cancer patients with disseminating disease. Although effective in
reducing tumor growth and size, the treatment selects for
androgen independent cancer cells, resulting in tumors resistant
to androgen therapy and progression into castration-resistant
prostate cancer [35]. Molecular interrogation of isolated circulat-
ing tumor cells would provide valuable information on tumor
progression and metastasis. It is crucial for future cell evaluation,
that the separation technology’s intrinsic properties do not alter
inflammatory cytokine IL-10 (f). The graphs show the results from at least three separate experiments and the data are shown as means 6 SD.
Significance value P,0.05, ns denotes non-significant.
doi:10.1371/journal.pone.0064233.g003
Figure 4. Prostate cancer cell viability is not affected by acoustophoresis. Cell viability was determined after acoustophoresis (0, 10 and 20
Vpp), for four prostate cancer cell lines: DU 145 (a), PC3 (b), LNCaP (c) and VCaP (d). Left panels show the percentage of cell death directly after
acoustophoresis measured by trypan blue exclusion. Right panels show the cell death quantified at 24 and 48 h after acoustophoresis by flow
cytometry. Cells negative for the DNA binding fluorochrome 7-Aminoactinmycin (7-AAD) were defined as viable. At least 10,000 cells were counted
and the percentage of dead cells was determined. Cells not subjected to acoustophoresis were used as control cells. The graphs show the results
from at least three separate experiments and the data are shown as means 6 SD. Significance value P,0.05, ns denotes non-significant.
doi:10.1371/journal.pone.0064233.g004
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Figure 5. Acoustic cell separation in a microchannel does not alter PSA secretion by prostate cancer cells. The androgen receptor (AR)
expressing cell lines LNCaP and VCaP were used to evaluate the impact of acoustophoresis on PSA secretion. After acoustophoresis run at 0, 10 and
20 Vpp, the secretion of PSA was measured in the absence or presence of the AR ligand R1881 (1 nM for 24 h) in the LNCaP cell line (a) and in the
VCaP cell line (b). Cells not processed through the chip were used as control cells. The graphs show the results from three separate experiments and
the data are shown as means 6 SD. Significance value P,0.05, ns denotes non-significant.
doi:10.1371/journal.pone.0064233.g005
Figure 6. Mitochondrial respiratory function in human leukocytes and thrombocytes are not altered following acoustophoresis.
Leukocytes and thrombocytes were passed through the acoustophoresis chip run at 0, 10 and 20 Vpp. Maximal respiration during using both complex
I- and complex II-linked substrates for thrombocytes (a) and leukotcytes (b) was unaltered after acoustophoresis, supporting that acoustophoresis
does not affect metabolic pathways important for respiration. The remaining respiratory activity following inhibition of ATP synthase with
oligomycin, so called Leak or state 4 respiration, was also unaffected by acoustophoresis, in thrombocytes (c) and leukocytes (d). This data confirm no
effect of acoustophoresis on inner mitochondrial membrane integrity or changed utilization of proton motive force for other purposes than ADP
phosphorylation. Unprocessed cells were used as control cells. The graphs show the results from three separate experiments and the data are shown
as means 6 SD. Significance value P,0.05, ns denotes non-significant.
doi:10.1371/journal.pone.0064233.g006
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any physical appearances or functional properties of the processed
cells. Here, we demonstrate that acoustophoresis affects neither
the responsiveness nor the endogenous PSA secretion or PSA
secretion induced by R1881 (a synthetic androgen), in prostate
cancer cells. Acoustophoresis may therefore be a suitable
technique for live CTC isolation from blood.
Mitochondria generate most of the cell’s supply of ATP through
oxidative phosphorylation. ATP is the main energy source for the
majority of cellular functions, including signal transduction
pathways, maintenance of cell structure, ion homeostasis and
locomotion. Any external influence on these cellular processes
leading to increased ATP demand will directly influence
mitochondrial ATP production rate. Acoustophoresis could thus
potentially influence mitochondrial activity indirectly by increasing
ATP production demand. Mitochondrial dysfunction is implicated
in numerous disorders [36] and is a common cause for drug-
induced toxicity [37]. An altered capacity of oxidative phosphor-
ylation may affect energy supply to the cell, redox state and
handling of reactive oxygen species, as well as apoptotic cell death
pathways [38]. Measuring cell respiration is an integrated
approach to assess mitochondrial function in cells [39]. Oxygen
consumption is directly proportional to the flux through the
electron transport chain. By using multiple substrates and
inhibitors of the respiratory chain complexes in intact and
permeabilized cells, perturbations of inner or outer mitochondrial
membrane integrity or decreased function of specific enzyme
complexes as well as differences in cellular energy demand can
readily be detected. No such differences could be detected
following acoustophoretic processing in the present study suggest-
ing that acoustophoresis is a gentle cell handling technology, not
causing any direct effect on essential mitochondrial function or
indirect effects on blood cell energy homeostasis.
Exposing cells to ultrasound standing wave conditions in
microfluidic systems can be harmful to the cells [40]. This
deleterious non-thermal effect of ultrasound is thought to be
related to acoustic cavitation. Other non-thermal acoustic effects,
such as acoustic radiation force and acoustic streaming is known to
be less detrimental. Cavitation is a phenomena where collapsing
gas bubbles can form jet streams under strong acoustic wave
exposures (typically ,1 MHz, reviewed in [14] that can punctu-
ate/rupture the cell membranes and thereby induce cell damage.
It should be noted that in this study, cells spend a very short time
in the high pressure zone of the standing wave along the side walls
and migrate to the central pressure minima in the middle of the
microchannel where the pressure variations are zero and
cavitation is unlikely to occur.
Long-term acoustic exposure times used for trapping cells have
typically demonstrated no alterations in cell viability. For example,
Wang et al. used hybridoma cells that were acoustically trapped
up to 6 min with maximum 0.24 J/m3 without detecting any
changes in cell viability [41]. Hultstro¨m and coauthors showed
normal cell growth in COS-7 cells, a fibroblast-like cell line from
monkey kidney, following 75 min of exposure to 0.85 MPa
(125 J/m3) [42]. Applying similar acoustic energy density, they
trapped human B cells for 3 days, demonstrating unaltered cell
division [43]. In another study, Bazou and colleagues studied
human liver carcinoma cells (HepG2) in an acoustic trap at 125 J/
m3 for 1 min and 14 J/m3 for 4 min without affecting cell death
and proliferation [19]. In a recent study exploring subtle cellular
alterations, Bazou et al. demonstrated gene expression analysis of
mouse embryonic stem cells levitated in a ultrasound standing
wave trap for 60 min at acoustic pressure of 125 J/m3 without
modifying pluripotency and gene expression [44]. Using high
acoustic energy densities of 12 800 J/m3 for 15 min, Yasuda and
colleagues focused erythrocytes at the pressure node without
detecting any leakage of potassium ions indicative of cell injury
[45]. Although most studies report a lack of acute adverse effect of
ultrasound, Radel et al. exposed yeast cells to ,150 J/m3 for 2 h
and discovered morphological changes related to the integrity of
the cell vacuole, which could be important for long-term studies
[46]. These findings were, however, observed for buffer systems
(ethanol/water mixture, 12%) where the yeast cells were not
confined to the pressure nodal plane but rather in the interstitial
space. The presence of ultrasound contrast agents can also affect
the cell viability at relatively small acoustic energy densities
(,150 J/m3) [47].
Comparing these long-term acoustic exposures with our
acoustophoresis systems where we typically use actuation voltage
of 10 Vpp (47 J/m
3) and an acoustic exposure time of 1 second for
efficient cell sorting, suggest that the present microfluidic system
provide a very gentle platform for cell sorting.
In conclusion, our findings suggest that microchannel acousto-
phoresis can be used for effective cell handling without having any
detectable effect on cell viability, inflammatory status, functional
phenotype or mitochondrial respiration.
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